164 related articles for article (PubMed ID: 25079908)
1. Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity.
Mannini B; Mulvihill E; Sgromo C; Cascella R; Khodarahmi R; Ramazzotti M; Dobson CM; Cecchi C; Chiti F
ACS Chem Biol; 2014 Oct; 9(10):2309-17. PubMed ID: 25079908
[TBL] [Abstract][Full Text] [Related]
2. Glycosaminoglycans (GAGs) suppress the toxicity of HypF-N prefibrillar aggregates.
Saridaki T; Zampagni M; Mannini B; Evangelisti E; Taddei N; Cecchi C; Chiti F
J Mol Biol; 2012 Aug; 421(4-5):616-30. PubMed ID: 22326346
[TBL] [Abstract][Full Text] [Related]
3. Salt anions promote the conversion of HypF-N into amyloid-like oligomers and modulate the structure of the oligomers and the monomeric precursor state.
Campioni S; Mannini B; López-Alonso JP; Shalova IN; Penco A; Mulvihill E; Laurents DV; Relini A; Chiti F
J Mol Biol; 2012 Dec; 424(3-4):132-49. PubMed ID: 23041425
[TBL] [Abstract][Full Text] [Related]
4. A causative link between the structure of aberrant protein oligomers and their toxicity.
Campioni S; Mannini B; Zampagni M; Pensalfini A; Parrini C; Evangelisti E; Relini A; Stefani M; Dobson CM; Cecchi C; Chiti F
Nat Chem Biol; 2010 Feb; 6(2):140-7. PubMed ID: 20081829
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
Cascella R; Conti S; Mannini B; Li X; Buxbaum JN; Tiribilli B; Chiti F; Cecchi C
Biochim Biophys Acta; 2013 Dec; 1832(12):2302-14. PubMed ID: 24075940
[TBL] [Abstract][Full Text] [Related]
6. Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations.
Cappelli S; Penco A; Mannini B; Cascella R; Wilson MR; Ecroyd H; Li X; Buxbaum JN; Dobson CM; Cecchi C; Relini A; Chiti F
Biol Chem; 2016 May; 397(5):401-15. PubMed ID: 26812789
[TBL] [Abstract][Full Text] [Related]
7. Structural differences between toxic and nontoxic HypF-N oligomers.
Capitini C; Patel JR; Natalello A; D'Andrea C; Relini A; Jarvis JA; Birolo L; Peduzzo A; Vendruscolo M; Matteini P; Dobson CM; De Simone A; Chiti F
Chem Commun (Camb); 2018 Aug; 54(62):8637-8640. PubMed ID: 30020284
[TBL] [Abstract][Full Text] [Related]
8. Conformational properties of the aggregation precursor state of HypF-N.
Campioni S; Mossuto MF; Torrassa S; Calloni G; de Laureto PP; Relini A; Fontana A; Chiti F
J Mol Biol; 2008 Jun; 379(3):554-67. PubMed ID: 18466920
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N.
Tatini F; Pugliese AM; Traini C; Niccoli S; Maraula G; Ed Dami T; Mannini B; Scartabelli T; Pedata F; Casamenti F; Chiti F
Neurobiol Aging; 2013 Sep; 34(9):2100-9. PubMed ID: 23601807
[TBL] [Abstract][Full Text] [Related]
10. Toxic oligomers of the amyloidogenic HypF-N protein form pores in mitochondrial membranes.
Farrugia MY; Caruana M; Ghio S; Camilleri A; Farrugia C; Cauchi RJ; Cappelli S; Chiti F; Vassallo N
Sci Rep; 2020 Oct; 10(1):17733. PubMed ID: 33082392
[TBL] [Abstract][Full Text] [Related]
11. Searching for conditions to form stable protein oligomers with amyloid-like characteristics: The unexplored basic pH.
Ahmad B; Winkelmann J; Tiribilli B; Chiti F
Biochim Biophys Acta; 2010 Jan; 1804(1):223-34. PubMed ID: 19836473
[TBL] [Abstract][Full Text] [Related]
12. Low-level expression of a folding-incompetent protein in Escherichia coli: search for the molecular determinants of protein aggregation in vivo.
Winkelmann J; Calloni G; Campioni S; Mannini B; Taddei N; Chiti F
J Mol Biol; 2010 May; 398(4):600-13. PubMed ID: 20346957
[TBL] [Abstract][Full Text] [Related]
13. Structure and dynamics of a partially folded protein are decoupled from its mechanism of aggregation.
Calloni G; Lendel C; Campioni S; Giannini S; Gliozzi A; Relini A; Vendruscolo M; Dobson CM; Salvatella X; Chiti F
J Am Chem Soc; 2008 Oct; 130(39):13040-50. PubMed ID: 18767849
[TBL] [Abstract][Full Text] [Related]
14. The induction of α-helical structure in partially unfolded HypF-N does not affect its aggregation propensity.
Ahmad B; Vigliotta I; Tatini F; Campioni S; Mannini B; Winkelmann J; Tiribilli B; Chiti F
Protein Eng Des Sel; 2011 Jul; 24(7):553-63. PubMed ID: 21518735
[TBL] [Abstract][Full Text] [Related]
15. Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism.
Limbocker R; Mannini B; Ruggeri FS; Cascella R; Xu CK; Perni M; Chia S; Chen SW; Habchi J; Bigi A; Kreiser RP; Wright AK; Albright JA; Kartanas T; Kumita JR; Cremades N; Zasloff M; Cecchi C; Knowles TPJ; Chiti F; Vendruscolo M; Dobson CM
Commun Biol; 2020 Aug; 3(1):435. PubMed ID: 32792544
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells.
Zampagni M; Cascella R; Casamenti F; Grossi C; Evangelisti E; Wright D; Becatti M; Liguri G; Mannini B; Campioni S; Chiti F; Cecchi C
J Cell Mol Med; 2011 Oct; 15(10):2106-16. PubMed ID: 21155974
[TBL] [Abstract][Full Text] [Related]
17. Structure of [NiFe] hydrogenase maturation protein HypE from Escherichia coli and its interaction with HypF.
Rangarajan ES; Asinas A; Proteau A; Munger C; Baardsnes J; Iannuzzi P; Matte A; Cygler M
J Bacteriol; 2008 Feb; 190(4):1447-58. PubMed ID: 18065529
[TBL] [Abstract][Full Text] [Related]
18. Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases.
Evangelisti E; Cascella R; Becatti M; Marrazza G; Dobson CM; Chiti F; Stefani M; Cecchi C
Sci Rep; 2016 Sep; 6():32721. PubMed ID: 27619987
[TBL] [Abstract][Full Text] [Related]
19. Structure of hydrogenase maturation protein HypF with reaction intermediates shows two active sites.
Petkun S; Shi R; Li Y; Asinas A; Munger C; Zhang L; Waclawek M; Soboh B; Sawers RG; Cygler M
Structure; 2011 Dec; 19(12):1773-83. PubMed ID: 22153500
[TBL] [Abstract][Full Text] [Related]
20. Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy.
Oropesa-Nuñez R; Seghezza S; Dante S; Diaspro A; Cascella R; Cecchi C; Stefani M; Chiti F; Canale C
Oncotarget; 2016 Jul; 7(29):44991-45004. PubMed ID: 27391440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
